ZTS

MKT CAP:$33B

Zoetis Inc

Market Cap

$33B

Healthcare·Drug Manufacturers - Specialty & Generic·🇺🇸 United States·NYSE

Healthcare·Drug·🇺🇸·NYSE

Stock Price

$78.82-$46.02 (-36.86%)

Jun 8, 2026

52W High $166.2452W Low $74.22

Company Details

Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry ...

CEO

—

IPO Date

Feb 1, 2013

Website

www.zoetis.com

Key Metrics TTM

Revenue

$9.5B

+2.4% YoY

Net Income

$2.6B

EPS (Diluted)

Free Cash Flow

$2.1B

Revenue / Share

$22.51

Gross Margin

70.8%

Operating Margin

37.6%

Net Margin

27.8%

FCF Margin

22.5%

P/S

3.4x

P/E

12.3x

Earnings Reports

Q2 2026

Aug 4, 2026

PENDING

Q1 2026

May 7, 2026

$2.3B+1.9%

FY 2025

Feb 12, 2026

$9.5B+2.3%

Q4 2025

Feb 12, 2026

$2.4B+3.0%

Q3 2025

Nov 4, 2025

$2.4B+0.5%

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee